Ethanol Effects on Human Astroglial Chemokine Expression

描述（由申请方提供）：白细胞和小胶质细胞的募集对中枢神经系统（CMS）的免疫活性很重要。星形胶质细胞衍生的趋化因子主要负责这些免疫细胞的趋化性。星形胶质细胞趋化因子也是许多生理事件，包括中枢神经系统发育所必需的。长期滥用酒精会导致脑部病变，并可能损害CNS免疫功能。这些酒精效应可能部分源于星形胶质细胞趋化因子表达的变化，因为星形胶质细胞是趋化因子的主要来源，并且有助于组织稳态，对损伤和免疫的反应。然而，乙醇对人类星形胶质细胞趋化因子表达的影响知之甚少。我们已经证明，在体外细胞迁移试验中，从脂多糖（LPS）+白细胞介素（IL）-Lp刺激的人A172星形胶质细胞的培养基诱导人U937白细胞的趋化性。星形胶质细胞诱导的白细胞趋化性部分地响应于星形胶质细胞分泌的趋化因子，干扰素-γ诱导蛋白-10（IP-10）。然而，当星形胶质细胞长期暴露于50 mM乙醇刺激前，IP-10的生产和白细胞趋化性降低。我们推测，乙醇暴露抑制人类星形胶质细胞趋化因子的表达。导致星形胶质细胞介导的白细胞和小胶质细胞的趋化性降低。星形细胞趋化因子表达减少也可能导致乙醇诱导的CNS病理，包括改变神经元发育。具体目标1：确定慢性乙醇暴露和乙醇戒断对促炎诱导的星形胶质细胞介导的白细胞和小胶质细胞趋化性的影响。将在体外用LPS、肽聚糖、细胞因子和/或HIV-1蛋白、达特和gp 120刺激人星形胶质细胞和A172细胞，以诱导趋化因子产生。人U937白细胞和CHME-5小胶质细胞对星形胶质细胞暴露的介质的趋化性将被用于识别乙醇敏感的刺激。具体目标2：确定慢性乙醇暴露和乙醇戒断对人类星形胶质细胞中促炎诱导的趋化因子表达的影响。将通过测量mRNA（RNA酶保护测定）和分泌蛋白（ELISA）水平来评估趋化因子表达。星形胶质细胞中乙醇敏感性趋化因子的鉴定将为深入研究乙醇调节趋化因子表达的机制提供起点。这一信息将有助于深入了解乙醇对神经病理学和CNS免疫活性的影响。预计这些信息最终将有助于开发新的脑病理学和CNS免疫反应的药理学操作，特别是与酒精滥用相关的。

DESCRIPTION (provided by applicant): Recruitment of leukocytes and microglia is important to immunocompetence in the central nervous system (CMS). Astrocyte-derived chemokines are largely responsible for chemotaxis of these immune cells. Astroglial chemokines are also essential to many physiological events, including CNS development. Chronic, abusive alcohol consumption causes brain pathologies and may compromise CNS immunocompetence. These alcohol effects may stem in part from changes in astroglial chemokine expression, as astroglia are a major source of chemokines and are instrumental in tissue homeostasis, response to injury and immunity. However, little is known about ethanol effects on chemokine expression in human astroglia. We have demonstrated in an in vitro cell migration assay, that media from lipopolysaccharide (LPS) + interleukin (IL)-lp-stimulated human A172 astroglia induces chemotaxis of human U937 leukocytic cells. Astrogial-induced leukocyte chemotaxis is partly in response to the chemokine, interferon-y inducible protein-10 (IP-10) secreted by the astroglia. Yet, when astroglia were chronically exposed to 50 mM ethanol prior to stimulation, IP-10 production and leukocyte chemotaxis were reduced. We hypothesize that ethanol exposure inhibits chemokine expression in human astroglia. resulting in reduced astroglial-mediated chemotaxis of leukocytes and microglia. Reduced astroqlial chemokine expression may also contribute to ethanol-induced CNS pathologies, including altered neuronal development. SPECIFIC AIM 1: Identify the effect of chronic ethanol exposure, and ethanol withdrawal, on proinflammatory-induced astroglial-mediated chemotaxis of leukocytes and microglia. Human astrocytes and A172 cells will be stimulated in vitro with LPS, peptidoglycan, cytokines and/or the HIV-1 proteins, Tat and gp120, to induce chemokine production. Chemotaxis of human U937 leukocytes and CHME-5 microglia in response to astroglialexposed media will be used to identify the stimuli that are ethanol-sensitive. SPECIFIC AIM 2: Identify the effect of chronic ethanol exposure, and ethanol withdrawal, on proinflammatory-induced chemokine expression in human astroglia. Chemokine expression will be assessed by measuring mRNA (RNase protection assay) and secreted protein (ELISA) levels. Identification of the ethanol-sensitive chemokine(s) in astroglia will provide a starting point for an indepth investigation into the mechanism by which ethanol modulates chemokine expression. This information will lend significant insight into the consequences of ethanol on neuropathology and CNS immunocompetence. It is anticipated that this information will ultimately be instrumental in the development of novel pharmacological manipulations of brain pathology and immune responsiveness in the CNS, especially as related to alcohol abuse.